(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SYNER-G

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SYNER-G

ST13

US500000097030468

Class

35, 42, 45

Filing

97030468

Registration

7198578

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

10/26/2023

Trademark type

Word

Nice classes

35, 42, 45

Filing date

09/16/2021

Registration date

10/24/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/24/2023

Last transaction

10/26/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

02/15/2008

First use in commerce

10/09/2012

Drawing code

4

Owner type

16

Owner location

Framingham, MA

Examiner

GAYNOR, BARBARA

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SYNER-G BIOPHARMA GROUP LLC
SYNER-G BIOPHARMA GROUP LLC
Syner-G Pharma Consulting, LLC

Representatives

Sara M. Bauer Womble Bond Dickinson (US) LLP

Technical classification

Nice Classes

Class 35Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing business intelligence services in the fields of pharmaceuticalsbiotechnologylife sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologiesspecificallybusiness consulting with respect to clinical developmentformulationevaluationapprovaldeliverycommercializationmarketinglife-cycle management of drugs; business servicesformulation of best practices for drug discoveryformulation developmentclinical suppliespharmacologytoxicologyclinical suppliesclinical development services; regulatory submission managementassisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies

Class 42

Consulting services in the fields of pharmaceutical research and developmentbiotechnologylife sciences; providing scientific research services in the fields of pharmaceutical design and developmentpharmaceutical chemistrypharmaceutical manufacturing and controls; consulting services regarding research and developmentpharmaceutical drug formulation developmentquality control for others in the fields of pharmaceuticalsbiotechnologylife sciences; technical advisory services in the fields of pharmaceutical research and developmentbiotechnologylife sciences; technical consulting in the fields of pharmaceutical research and developmentbiotechnologylife sciences; technical consulting servicesevaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticalsbiotechnologylife sciences; Consulting services for others in the field of designplanningimplementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testinganalysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticalsbiotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials

Class 45

Regulatory compliance consulting in the fields of pharmaceuticalsbiotechnologylife sciences

Publications

History of USPTO decisions and trademark events.

24 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/26/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/26/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/26/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/26/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/26/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/24/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/24/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/08/2023

PUBO

PUBLISHED FOR OPPOSITION

08/08/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/19/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/05/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/03/2023

GNSL

LETTER OF SUSPENSION E-MAILED

01/03/2023

CNSL

SUSPENSION LETTER WRITTEN

01/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/06/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/05/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/22/2022

GNRT

NON-FINAL ACTION E-MAILED

06/22/2022

CNRT

NON-FINAL ACTION WRITTEN

06/22/2022

DOCK

ASSIGNED TO EXAMINER

06/21/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/21/2021

NWAP

NEW APPLICATION ENTERED

09/20/2021

Continuous trademark protection

Get notified about every new filing that threatens SYNER-G or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.